SCHEMBL16991845

SCHEMBL16991845

COc1ccc(CN(C(=O)OC(C)(C)C)[C@@H](C(=O)O)c2ccncc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ USP2 O75604 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ LDHA P00338 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CYP17A1 P05093 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ NR1D1 P20393 1/20 0.39
▸ BMP1 P13497 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ YAP1 P46937 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30528327 0.88 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HTTGAAMAPT
SCHEMBL11579749 0.80 LDHA (0.43) ALDH1A1SMN1; SMN2HTTUSP2TSHR
SCHEMBL10519344 0.80 LDHA (0.43) ALDH1A1SMN1; SMN2HTTUSP2TSHR
SCHEMBL11400130 0.80 LDHA (0.43) ALDH1A1SMN1; SMN2HTTUSP2TSHR
SCHEMBL16991848 0.79 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2HTTGAAMAPT
SCHEMBL8893537 0.79 LDHA (0.44) ALDH1A1SMN1; SMN2HTTLDHATDP1
SCHEMBL11148899 0.78 LDHA (0.43) ALDH1A1SMN1; SMN2HTTGAAMAPT
SCHEMBL5494081 0.78 LDHA (0.43) ALDH1A1SMN1; SMN2HTTLDHATDP1
SCHEMBL24291657 0.77 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTLDHATDP1
SCHEMBL18204035 0.76 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TDP1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3102200-A2 THERAPEUTIC COMPOUNDS AND COMPOSITIONS Exithera Pharmaceuticals Inc. (US) 2016-12-14 — — EP disclosed
WO-2015120062-A2 THERAPEUTIC COMPOUNDS AND COMPOSITIONS eXIthera Pharmaceuticals Inc. (US) 2015-08-13 — — WO disclosed
Send feedback